Search Orphan Drug Designations and Approvals
-
Generic Name: | Autologous CD4+/CD8+ T cells expressing a BCMA-specific chimeric antigen receptor (CAR) |
---|---|
Date Designated: | 09/28/2017 |
Orphan Designation: | Treatment of Multiple Myeloma (MM) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Juno Therapeutics, Inc. 400 Dexter Avenue North Suite 1200 Seattle, Washington 98109 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-